| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 27 Mar 2025 | 15 Mar 2025 |
| Bio Green Papers Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/03/2025 inter alia to consider and approve To consider and approve The terms and conditions and other related matters in connection with the Rights Issue of Equity Shares. Bio Green Papers Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/03/2025 ,inter alia, to consider and approve Terms and conditions and other related matters concerning the rights issue of Equity Shares (As per BSE Announcement Dated on 19/03/2025) Rights Issue Committee Approved the Terms of Rights Issue (As Per BSE Announcement Dated on: 27/03/2025) | ||
| Board Meeting | 15 Mar 2025 | 11 Mar 2025 |
| Bio Green Papers Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/03/2025 ,inter alia, to consider and approve Determination of Rights issue price and related payment mechanism, issue size, Rights Entitlement Ratio. Rights Issue Committee of the Board of Directors of the Company at its Meeting held on today has considered and approved the Terms of the Rights Issue. (As Per Bse Announcement Dated on 15.03.2025) | ||
| Board Meeting | 12 Feb 2025 | 4 Feb 2025 |
| Bio Green Papers Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 ,inter alia, to consider and approve The Un-Audited Standalone and Consolidated Financial Results for the quarter ended on 31-12-2024. Submission of Un Audited Standalone & Consolidated Financial Results and Limited Review Report for The Quarter ended 31st December,2024. (As Per BSE Announcement Dated on 12/02/2025) | ||
| Board Meeting | 29 Jan 2025 | 26 Jan 2025 |
| Bio Green Papers Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2025 inter alia to consider and approve The Draft Offer Letter In connection with the proposed Rights Issue. Rights Issue Committee Considered and Approved the Draft Letter of Offer in relation to proposed Rights issue. (As Per BSE Announcement Dated on: 29/01/2025) | ||
| Board Meeting | 24 Jan 2025 | 17 Jan 2025 |
| Bio Green Papers Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/01/2025 inter alia to consider and approve The Proposal For Fund Raising by issue of Equity Shares through Rights Issue. The Board Considered and Approved the offer and issue of fully paid-up equity shares of the company for an amount not exceeding Rs.49,90,00,000.00 through Rights Issue. (As Per BSE Announcement dated on 24.01.2025) | ||
| Board Meeting | 12 Nov 2024 | 5 Nov 2024 |
| Bio Green Papers Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2024 inter alia to consider and approve Standalone and Consolidated Un-Audited Financial Results for the quarter and Half Year ended 30th September 2024. Disclosure under Regulation 30 SEBI (LODR) Regulations 2015. Approval of Un-Audited Stand alone consolidated Financial Results along with statement of Assets and Liabilities and CFS for the Quarter and half year ended on 30th september,2024 approved on this 12th November,2024. (As Per Bse Announcement Dated on 12.11.2024) | ||
| Board Meeting | 6 Sep 2024 | 5 Sep 2024 |
| Bio Green Papers Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/09/2024 inter alia to consider and approve along with other business items the following: 1. To consider and approve the Notice of 30th Annual General Meeting and Directors Report of the Company for the FY 2023-24 ended 31st March 2024. 2. Constitution of various committees of the Board as per the Companies Act 2013 and SEBI (Listing Obligation and Disclosure Requirements) Regulations 2105. 3. To Consider and approve the increase in the Authorised Capital of the Company 4. To consider and approve the Employee Stock Option Plan for the Employees of the Company its subsidiaries and Associates. Pursuant to Regulation 30 and other applicable Regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and with reference to captioned subject, we wish to inform that, the Board of Directors of the Company, have at their meeting held on Friday, the 6th day of September, 2024, interalia, considered and approved the following businesses along with other businesses: approved the Notice convening 30th Annual General Meeting (Financial Year 2023-24) of the Company to be held on 30th September, 2024. (As Per BSE Announcement Dated on: 06/09/2024) | ||
| Board Meeting | 13 Aug 2024 | 7 Aug 2024 |
| Bio Green Papers Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 inter alia to consider and approve 1. Audited Standalone Financial Statements of the Company for the FY 2023-24 ended 31st March 2024. 2. Audited Consolidated Financial Statements of the Company for the FY 2023-24 ended 31st March 2024. 3. Un-audited Standalone Financial Results of the Company for 1st Quarter of FY 2024-25 ended 30th June 2024. 4. Un-audited Consolidated Financial Results of the Company for 1st Quarter of FY 2024-25 ended 30th June 2024. 5. Allotment of 5000000 fully paid-up equity shares to identified individuals on preferential basis as per the resolution plan approved by the Honble national company law tribunal Hyderabad Bench. 6. Adoption of new set of Articles of Association of the company in accordance with Companies Act 2013 and pursuant to resolution plan. 7. Constitution of various committees of the Board as per the Companies Act 2013 and SEBI (Listing Obligation and Disclosure Requirements) Regulations 2105. Standalone and Consolidated Audited Financial Statements of the Company for the FY 2023-24 ended 31st March 2024 (As Per Bse Announcement Dated on 13.08.2024) | ||
| Board Meeting | 22 Jun 2024 | 6 Jun 2024 |
| Reduction of Capital & Preferential Issue of shares Pursuant to regulation 30 and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and pursuant to implementation of resolution plan as approved by the Honble NCLT, Hyderabad Bench vide its order dated 28th May, 2024, we wish to inform that, the Board of Directors of the Company, have at their meeting held on Saturday, the 22nd day of June, 2024, interalia along with other businesses, the businesses enclosed in the document attached herewith. This is for your information and records (As per BSE Announcement Dated on 22/06/2024) | ||
| Board Meeting | 5 Jun 2024 | 5 Jun 2024 |
| Outcome of the meeting of the Board of Directors of the Company held on 05th June 2024 The Board of Directors of the Company at their meeting held on 5th June 2024 approved the shifting of the registered office of the Company within the city limits. The new registered office of the Company with immediate effect shall be situated at Sy.No 66/2, Street No. 3, 2nd Floor, TVS Avenue, Raidurgam, Prashanti Hills, Nav Khalsa, gachibowli, Rangareddy, Hyderabad Telangana 500008. Pursuant to the NCLT Order dated 28th May 2024, the Board of Directors of the Company at their meeting held on 5th June 2024, fixed 21st June 2024 as the Record Date for the following Corporate Actions: 1. Extinguishment of Entire Promotor Holding as on the record date without any payout 2. Extinguishment/ Cancellation of 95% of the equity shares held by the public shareholders as on the record date such that, the public shareholder shall hold one equity share of the Company for each 20 shares held by him as on the record date (Balance Shares being cancelled without any payout) The Board of Directors of the Company at their meeting held on 05th June 2024 approved the appointment of following directors as mentioned in the disclosure, with immediate effect. Further the Board of Directors of the Company approved the resignation of all the Directors and KMPs of the Company appearing as on the date of NCLT Order with effect from 31.05.2024. The details of the same are mentioned in the Disclosure enclosed herewith The Board of Directors of the Company at their meeting held on 5ht June 2024, approved the change in Objects and Capital Clause of the Memorandum of Association of the Company, pursuant to the approved Resolution Plan, vide NCLT Order dated 28th May 2024. The details of the same forms part of the Disclosure enclosed herewith | ||
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
